Island Pharmaceuticals Ltd

Q: What was Island Pharmaceuticals Ltd’s price range in the past 12 months?

Island Pharmaceuticals Ltd lowest share price was AU$0.11 and its highest was AU$0.51 in the past 12 months.

Q: What is Island Pharmaceuticals Ltd’s market cap?

Island Pharmaceuticals Ltd’s market cap is AU$88.88M.

Q: When is Island Pharmaceuticals Ltd’s upcoming earnings report date?

Island Pharmaceuticals Ltd’s upcoming earnings report date is Feb 19, 2026 which is in 111 days.

Q: How were Island Pharmaceuticals Ltd’s earnings last quarter?

Island Pharmaceuticals Ltd released its earnings results on Aug 28, 2025. The company reported -AU$0.012 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.012.

Q: Is Island Pharmaceuticals Ltd overvalued?

According to Wall Street analysts Island Pharmaceuticals Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: Does Island Pharmaceuticals Ltd pay dividends?

Island Pharmaceuticals Ltd does not currently pay dividends.

Q: What is Island Pharmaceuticals Ltd’s EPS estimate?

Island Pharmaceuticals Ltd’s EPS estimate for its next earnings report is not yet available.

Q: How many shares outstanding does Island Pharmaceuticals Ltd have?

Island Pharmaceuticals Ltd has 253,956,760 shares outstanding.

Q: What happened to Island Pharmaceuticals Ltd’s price movement after its last earnings report?

Island Pharmaceuticals Ltd reported an EPS of -AU$0.012 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Q: Which hedge fund is a major shareholder of Island Pharmaceuticals Ltd?

Currently, no hedge funds are holding shares in AU:ILA

Compare

17 Followers

ILA Stock Chart & Stats

AU$0.40

<AU$0.01(1.74%)

At close: Jan 09 4:00 PM EST

AU$0.40

<AU$0.01(1.74%)

Day’s Range― - ―

52-Week RangeAU$0.11 - AU$0.51

Previous CloseN/A

Volume208.69K

Average Volume (3M)781.24K

Market Cap

AU$88.88M

Enterprise ValueAU$20.79M

Total Cash (Recent Filing)AU$7.25M

Total Debt (Recent Filing)AU$0.00

Price to Earnings (P/E)―

Beta0.58

Next Earnings

Feb 19, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.01

Shares Outstanding253,956,760

10 Day Avg. Volume388,484

30 Day Avg. Volume781,243

Financial Highlights & Ratios

PEG Ratio0.22

Price to Book (P/B)3.39

Price to Sales (P/S)204.10

P/FCF Ratio-8.77

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

Island Pharmaceuticals Ltd News

Island Pharmaceuticals Issues New Shares to Bolster Financial Position

An update from Island Pharmaceuticals Ltd ( ($AU:ILA) ) is now available. Island Pharmaceuticals Limited has issued 666,666...

1d ago

ILA

Island Pharmaceuticals Advances Galidesivir Antiviral Program with Strategic Acquisition

The latest announcement is out from Island Pharmaceuticals Ltd ( ($AU:ILA) ). Island Pharmaceuticals Ltd has completed the...

1d ago

ILA

Island Pharmaceuticals Awaits FDA Feedback on Galidesivir Amidst US Shutdown

Island Pharmaceuticals Ltd ( ($AU:ILA) ) has issued an announcement. Island Pharmaceuticals Ltd announced that the US FDA...

9d ago

ILA

Island Pharmaceuticals Announces Quotation of New Securities on ASX

Island Pharmaceuticals Ltd ( ($AU:ILA) ) has shared an announcement. Island Pharmaceuticals Ltd has announced the quotation of...

14d ago

ILA

Island Pharmaceuticals Ltd Concludes Annual General Meeting with Key Resolutions Passed

Island Pharmaceuticals Ltd ( ($AU:ILA) ) has issued an announcement. Island Pharmaceuticals Ltd held its Annual General Meeting,...

22d ago

ILA

Island Pharmaceuticals Issues Unquoted Securities to Employees

The latest update is out from Island Pharmaceuticals Ltd ( ($AU:ILA) ). Island Pharmaceuticals Ltd has announced the...

28d ago

ILA

Island Pharmaceuticals Advances Galidesivir Approval with FDA Submission

Island Pharmaceuticals Ltd ( ($AU:ILA) ) has shared an announcement. Island Pharmaceuticals Ltd has submitted a comprehensive briefing...

1M ago

ILA

Island Pharmaceuticals Secures FDA Meeting to Fast-Track Galidesivir Approval

Island Pharmaceuticals Ltd ( ($AU:ILA) ) has shared an update. Island Pharmaceuticals Ltd has announced that the US...

1M ago

ILA

Island Pharmaceuticals to Host Webinar on Galidesivir Program Update

Island Pharmaceuticals Ltd ( ($AU:ILA) ) has issued an announcement. Island Pharmaceuticals Ltd announced a webinar to update...

1M ago

ILA

Island Pharmaceuticals Reports Promising Galidesivir Study Results

The latest announcement is out from Island Pharmaceuticals Ltd ( ($AU:ILA) ). Island Pharmaceuticals Ltd announced promising results...

1M ago

ILA

ILA FAQ

What was Island Pharmaceuticals Ltd’s price range in the past 12 months?

Island Pharmaceuticals Ltd lowest share price was AU$0.11 and its highest was AU$0.51 in the past 12 months.

What is Island Pharmaceuticals Ltd’s market cap?

Island Pharmaceuticals Ltd’s market cap is AU$88.88M.

When is Island Pharmaceuticals Ltd’s upcoming earnings report date?

Island Pharmaceuticals Ltd’s upcoming earnings report date is Feb 19, 2026 which is in 111 days.

How were Island Pharmaceuticals Ltd’s earnings last quarter?

Island Pharmaceuticals Ltd released its earnings results on Aug 28, 2025. The company reported -AU$0.012 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.012.

Is Island Pharmaceuticals Ltd overvalued?

According to Wall Street analysts Island Pharmaceuticals Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Island Pharmaceuticals Ltd pay dividends?

Island Pharmaceuticals Ltd does not currently pay dividends.

What is Island Pharmaceuticals Ltd’s EPS estimate?

Island Pharmaceuticals Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Island Pharmaceuticals Ltd have?

Island Pharmaceuticals Ltd has 253,956,760 shares outstanding.

What happened to Island Pharmaceuticals Ltd’s price movement after its last earnings report?

Island Pharmaceuticals Ltd reported an EPS of -AU$0.012 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Island Pharmaceuticals Ltd?

Currently, no hedge funds are holding shares in AU:ILA

Island Pharmaceuticals Ltd Stock Smart Score

Neutral

Fundamentals

Return on Equity

-90.37%

Trailing 12-Months

Asset Growth

192.19%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Island Pharmaceuticals Ltd

Island Pharmaceuticals Ltd (ILA) is a biopharmaceutical company focused on developing and commercializing innovative therapies for the prevention and treatment of mosquito-borne viral diseases. The company's primary focus is on its lead product, ISLA-101, a drug aimed at preventing and treating dengue fever and other flavivirus infections. Island Pharmaceuticals leverages its expertise in viral disease research and drug development to address significant unmet medical needs in global health.